Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 15/01/2026 pm IST			5-day change	1st Jan Change
365.20 ^DKK	-3.45%		-1.39%	+12.28%

16/01	Trump Launches Health Care Plan to Reduce Drug Costs	MT
15/01	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,07,50,00,000	0	0	70.25 %
Stock B	1	3,39,00,00,000	3,13,65,64,503 ( 92.52 %)	2,40,00,000 ( 0.708 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	17,75,60,500	5.238 %	9 093 M kr
NOVO NORDISK A/S 0.7654 %	2,59,47,151	0.7654 %	1 329 M kr
Nordea Investment Management AB 0.1362 %	46,15,714	0.1362 %	236 M kr
ODIN Forvaltning AS 0.1355 %	45,93,090	0.1355 %	235 M kr
Sjunde AP-fonden 0.1328 %	45,02,464	0.1328 %	231 M kr
State Street Global Advisors Ltd. 0.1264 %	42,86,450	0.1264 %	220 M kr
Nykredit Bank A/S (Investment Management) 0.125 %	42,36,678	0.125 %	217 M kr
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 0.1107 %	37,52,984	0.1107 %	192 M kr
Capfi Delen Asset Management NV 0.0857 %	29,06,285	0.0857 %	149 M kr
Storebrand Asset Management AS 0.0813 %	27,55,326	0.0813 %	141 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.000008 %	2,270	0.000008 %	14 857 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,07,48,72,000	100 %	55 045 M kr
ANIMA Sgr SpA 0.0108 %	1,15,783	0.0108 %	6 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	20 741 kr

Name	Equities	%	Valuation
Capital Research & Management Co. (International Investors) 0.5225 %	1,77,13,424	0.5225 %	901 M kr
Loomis, Sayles & Co. LP 0.4768 %	1,61,65,468	0.4768 %	822 M kr
Fidelity Management & Research Co. LLC 0.4152 %	1,40,75,391	0.4152 %	716 M kr
Fiduciary Trust Company International 0.4125 %	1,39,84,789	0.4125 %	712 M kr
Merrill Lynch International 0.3954 %	1,34,03,378	0.3954 %	682 M kr
Eaton Vance Management 0.3662 %	1,24,13,429	0.3662 %	632 M kr
Fisher Asset Management LLC 0.3045 %	1,03,22,903	0.3045 %	525 M kr
Folketrygdfondet 0.3012 %	1,02,11,913	0.3012 %	520 M kr
Wells Fargo Bank NA 0.223 %	75,59,665	0.223 %	385 M kr
Fayez Sarofim & Co. LLC 0.2169 %	73,53,587	0.2169 %	374 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	47.63%
Other	1.18%
Novo Nordisk A/S	0.77%
State Street Corp.	0.18%
Markel Group, Inc.	0.07%
Individuals	0.01%
Banco Bilbao Vizcaya Argentaria SA	0.01%
SEI Investments Co.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Unknown	50.13%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.93%
United States	7.45%
United Kingdom	1.15%
Norway	0.75%
Sweden	0.39%
Canada	0.34%
Germany	0.34%
Finland	0.19%
Ireland	0.17%
Spain	0.16%
Luxembourg	0.16%
Italy	0.14%
France	0.13%
Belgium	0.1%
Switzerland	0.09%
Netherlands	0.07%
Australia	0.06%
Austria	0.05%
South Africa	0.03%
Japan	0.02%
Singapore	0.02%
Slovenia	0.02%
Israel	0.02%
Hong Kong	0.02%
Portugal	0.01%
Individuals	0.01%
Mexico	0.01%
Iceland	0.01%
Liechtenstein	0.01%
Puerto Rico	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.6%); - rare disease treatment products (6.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (20.8%), the United States (57.6%), North America (3.7%), China (6.4%) and other (11.5%).

Employees

78,554

Sector

Pharmaceuticals

Calendar

04/02 - Q4 2025 Earnings Release

More about the company